Tapewire

Nasdaq · USD

KRYS

Krystal Biotech, Inc.

Export transactions ↓
Tapewire entity
3500
SEC CIK
0001711279
Parsed reports
185

Last 12 months

Inside the activity.

0 purchase rows · 142 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 2025032
Jan 202600
Feb 2026031
Mar 2026021
Apr 202600
May 202601
Jun 2026023
Jul 202600
Aug 202608
Sep 2026026
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
August 05, 2022 Filed Aug 9, 2022 20:54 UTC
Krishnan Krish SDirector · President and CEO · 10% owner
SaleCommon Stock 13,058 $81.61 $1,065,638.57
Disclosure

SEC source: 0001298709-22-000005 · wf-form4_166007846224417.xml · nonDerivative · entry 2

Krishnan Krish S · CIK 0001298709 · Director · President and CEO · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,791,542

F1 · kind: The sales reported were pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. The Rule 10b5-1 trading plan started on July 15, 2022 and will terminate on July 15, 2023 and contemplates quarterly sales of 25,000 shares with a limit price of $80.00 per share.

F3 · price: The transaction was executed in multiple trades ranging from $81.0100 to $82.0000. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.

Read SEC document
August 05, 2022 Filed Aug 9, 2022 20:54 UTC
Krishnan Krish SDirector · President and CEO · 10% owner
SaleCommon Stock 9,088 $80.24 $729,208.40
Disclosure

SEC source: 0001298709-22-000005 · wf-form4_166007846224417.xml · nonDerivative · entry 1

Krishnan Krish S · CIK 0001298709 · Director · President and CEO · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,804,600

F1 · kind: The sales reported were pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. The Rule 10b5-1 trading plan started on July 15, 2022 and will terminate on July 15, 2023 and contemplates quarterly sales of 25,000 shares with a limit price of $80.00 per share.

F2 · price: The transaction was executed in multiple trades ranging from $80.0000 to $80.9700. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.

Read SEC document
June 30, 2022 Filed Jul 1, 2022 20:18 UTC GrantStock Option (Right to Buy) · Derivative 6,800 $0.00 Strike: $65.66 $0.00
Disclosure

SEC source: 0001711279-22-000042 · wf-form4_165670668078150.xml · derivative · entry 1

Sutherland Everett Rand · CIK 0001852880 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,800

Underlying: Common Stock · 6,800 shares

Expires 2032-06-30

F1 · derivative.exercise_date: The options were awarded on June 30, 2022 and vest in equal monthly tranches over a one-year period.

Read SEC document
June 30, 2022 Filed Jul 1, 2022 20:15 UTC
ROSSI DINO ADirector
GrantStock Option (Right to Buy) · Derivative 6,800 $0.00 Strike: $65.66 $0.00
Disclosure

SEC source: 0001711279-22-000040 · wf-form4_165670651988931.xml · derivative · entry 1

ROSSI DINO A · CIK 0001209059 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,800

Underlying: Common Stock · 6,800 shares

Expires 2032-06-30

F1 · derivative.exercise_date: The options were awarded on June 30, 2022 and vest in equal monthly tranches over a one-year period.

Read SEC document
June 30, 2022 Filed Jul 1, 2022 20:12 UTC GrantStock Option (Right to Buy) · Derivative 6,800 $0.00 Strike: $65.66 $0.00
Disclosure

SEC source: 0001711279-22-000038 · wf-form4_165670631803960.xml · derivative · entry 1

JANNEY DANIEL · CIK 0001198325 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,800

Underlying: Common Stock · 6,800 shares

Expires 2032-06-30

F1 · derivative.exercise_date: The options were awarded on June 30, 2022 and vest in equal monthly tranches over a one-year period.

Read SEC document
June 30, 2022 Filed Jul 1, 2022 20:09 UTC GrantStock Option (Right to Buy) · Derivative 6,800 $0.00 Strike: $65.66 $0.00
Disclosure

SEC source: 0001711279-22-000036 · wf-form4_165670614389935.xml · derivative · entry 1

Mason Christopher · CIK 0001836440 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,800

Underlying: Common Stock · 6,800 shares

Expires 2032-06-30

F1 · derivative.exercise_date: The options were awarded on June 30, 2022 and vest in equal monthly tranches over a one-year period.

Read SEC document
June 30, 2022 Filed Jul 1, 2022 20:05 UTC GrantStock Option (Right to Buy) · Derivative 6,800 $0.00 Strike: $65.66 $0.00
Disclosure

SEC source: 0001711279-22-000034 · wf-form4_165670592393510.xml · derivative · entry 1

Gangolli Julian S · CIK 0001532023 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,800

Underlying: Common Stock · 6,800 shares

Expires 2032-06-30

F1 · derivative.exercise_date: The options were awarded on June 30, 2022 and vest in equal monthly tranches over a one-year period.

Read SEC document
February 28, 2022 Filed Mar 1, 2022 21:22 UTC
ORTH ANDREW C.Chief Commercial Officer
GrantStock Option (Right to Buy) · Derivative 50,000 $0.00 Strike: $63.55 $0.00
Disclosure

SEC source: 0001860010-22-000002 · wf-form4_164618775853736.xml · derivative · entry 2

ORTH ANDREW C. · CIK 0001860010 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 50,000

Underlying: Common Stock · 50,000 shares

Expires 2032-02-28

F1 · derivative.exercise_date: The option vests in four equal annual installments beginning on February 28, 2023.

Read SEC document
February 28, 2022 Filed Mar 1, 2022 21:25 UTC
ROMANO KATHRYNChief Accounting Officer
GrantStock Option (Right to Buy) · Derivative 50,000 $0.00 Strike: $63.55 $0.00
Disclosure

SEC source: 0001801385-22-000005 · wf-form4_164618791185342.xml · derivative · entry 2

Romano Kathryn · CIK 0001801385 · Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 50,000

Underlying: Common Stock · 50,000 shares

Expires 2032-02-28

F3 · derivative.exercise_date: The option vests in four equal annual installments beginning on February 28, 2023.

Read SEC document
February 28, 2022 Filed Mar 2, 2022 02:20 UTC
Krishnan SumaDirector · President, R&D · 10% owner
GrantStock Option (Right to Buy) · Derivative 50,000 $0.00 Strike: $63.55 $0.00
Disclosure

SEC source: 0001298711-22-000003 · wf-form4_164618760010701.xml · derivative · entry 5

Krishnan Suma · CIK 0001298711 · Director · President, R&D · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 50,000

Underlying: Common Stock · 50,000 shares

Expires 2032-02-28

F5 · derivative.exercise_date: The option vests in four equal annual installments beginning on February 28, 2023.

Read SEC document
February 28, 2022 Filed Mar 2, 2022 02:18 UTC
Krishnan Krish SDirector · President and CEO · 10% owner
GrantStock Option (Right to Buy) · Derivative 50,000 $0.00 Strike: $63.55 $0.00
Disclosure

SEC source: 0001298709-22-000003 · wf-form4_164618746275382.xml · derivative · entry 5

Krishnan Krish S · CIK 0001298709 · Director · President and CEO · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 50,000

Underlying: Common Stock · 50,000 shares

Expires 2032-02-28

F5 · derivative.exercise_date: The option vests in four equal annual installments beginning on February 28, 2023.

Read SEC document
February 26, 2022 Filed Mar 1, 2022 21:25 UTC
ROMANO KATHRYNChief Accounting Officer
Tax withholdingCommon Stock 1,472 $62.50 $92,000.00
Disclosure

SEC source: 0001801385-22-000005 · wf-form4_164618791185342.xml · nonDerivative · entry 1

Romano Kathryn · CIK 0001801385 · Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,128

F1 · shares: Represents tax withholding upon the vesting of 4,900 shares of restricted stock on February 26, 2022.

F2 · price: The closing price on February 25, 2022 of the Company's common stock on NASDAQ.

Read SEC document
February 26, 2022 Filed Mar 2, 2022 02:20 UTC
Krishnan SumaDirector · President, R&D · 10% owner
Tax withholdingCommon Stock 3,282 $62.50 $205,125.00
Disclosure

SEC source: 0001298711-22-000003 · wf-form4_164618760010701.xml · nonDerivative · entry 1

Krishnan Suma · CIK 0001298711 · Director · President, R&D · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,752,263

F1 · shares: Represents tax withholding upon the vesting of 7,100 shares of restricted stock on February 26, 2022.

F2 · price: The closing price on February 25, 2022 of the Company's common stock on NASDAQ.

Read SEC document
February 26, 2022 Filed Mar 2, 2022 02:18 UTC
Krishnan Krish SDirector · President and CEO · 10% owner
Tax withholdingCommon Stock 4,655 $62.50 $290,937.50
Disclosure

SEC source: 0001298709-22-000003 · wf-form4_164618746275382.xml · nonDerivative · entry 1

Krishnan Krish S · CIK 0001298709 · Director · President and CEO · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,813,688

F1 · shares: Represents tax withholding upon the vesting of 10,200 shares of restricted stock on February 26, 2022.

F2 · price: The closing price on February 25, 2022 of the Company's common stock on NASDAQ.

Read SEC document
January 31, 2022 Filed Jan 31, 2022 21:47 UTC GrantStock Option (Right to Buy) · Derivative 13,600 $0.00 Strike: $59.00 $0.00
Disclosure

SEC source: 0001852880-22-000002 · wf-form4_164366560575664.xml · derivative · entry 1

Sutherland Everett Rand · CIK 0001852880 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,600

Underlying: Common Stock · 13,600 shares

Expires 2032-01-31

F1 · derivative.exercise_date: The options were awarded on January 31, 2022 and vest in equal monthly tranches over a three-year period.

Read SEC document
January 31, 2022 Filed Jan 31, 2022 22:27 UTC
Marantz Jing L.Chief Business Officer
GrantStock Option (Right to Buy) · Derivative 205,000 $0.00 Strike: $59.00 $0.00
Disclosure

SEC source: 0001834528-22-000003 · wf-form4_164366801686527.xml · derivative · entry 1

Marantz Jing L. · CIK 0001834528 · Chief Business Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 205,000

Underlying: Common Stock · 205,000 shares

Expires 2032-01-31

F1 · derivative.exercise_date: The options were awarded on January 31, 2022 and vest in four equal annual installments beginning on January 31, 2023.

Read SEC document
December 30, 2021 Filed Feb 2, 2022 21:38 UTC GiftCommon Stock 34,000 $0.00 $0.00
Disclosure

SEC source: 0001062993-22-002225 · form5.xml · nonDerivative · entry 1

JANNEY DANIEL · CIK 0001198325 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 232,362

F1 · shares: The Reporting Person transferred these shares of common stock to a charitable trust, over which the Reporting Person has no pecuniary interest or investment control.

Read SEC document
December 10, 2021 Filed Dec 14, 2021 21:14 UTC
Krishnan SumaDirector · Chief Operating Officer · 10% owner
SaleCommon Stock 100,000 $70.50 $7,050,000.00
Disclosure

SEC source: 0000899243-21-048125 · doc4.xml · nonDerivative · entry 1

Krishnan Suma · CIK 0001298711 · Director · Chief Operating Officer · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · By trust

Disclosed balance after: 50,000

F1 · shares: On December 3, 2021, Krystal Biotech, Inc. (the "Company"), closed the previously announced underwritten public offering of 2,666,667 shares of its common stock, at a public offering price of $75.00 per share. The Company and certain selling stockholders granted the underwriters a 30-day option to purchase up to an additional 400,000 shares of the Company's common stock offered in the public offering, which includes up to 200,000 shares from the selling stockholders. The underwriters exercised the option and on December 10, 2021, purchased the 400,000 shares of the Company's common stock, including 100,000 shares of the Company's common stock from the Krishnan Family Trust, a selling stockholder.

F2 · ownership.nature: Directly beneficially owned by the Krishnan Family Trust. The reporting person and her spouse are each joint beneficial owners of the trust with joint voting and investment control.

F3 · ownership.nature: Prior to the reported transaction, the Krishnan Family Trust held 112,162 shares. In connection with the reported transaction, 18,919 shares were transferred to the Krishnan Family Trust from the reporting person's individual account and 18,919 shares were transferred to the Krishnan Family Trust from Krish Krishnan's, the reporting person's spouse, individual account.

Read SEC document
December 10, 2021 Filed Dec 14, 2021 21:11 UTC SaleCommon Stock 100,000 $70.50 $7,050,000.00
Disclosure

SEC source: 0000899243-21-048122 · doc4.xml · nonDerivative · entry 1

JANNEY DANIEL · CIK 0001198325 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By Alta Bioequities L.P

Disclosed balance after: 266,362

F1 · shares: On December 3, 2021, Krystal Biotech, Inc. (the "Company"), closed the previously announced underwritten public offering of 2,666,667 shares of its common stock, at a public offering price of $75.00 per share. The Company and certain selling stockholders granted the underwriters a 30-day option to purchase up to an additional 400,000 shares of the Company's common stock offered in the public offering, which includes up to 200,000 shares from the selling stockholders. The underwriters exercised the option and on December 10, 2021, purchased the 400,000 shares of the Company's common stock, including 100,000 shares of the Company's common stock from Alta Bioequities, L.P., a selling stockholder.

F2 · ownership.nature: Alta Bioequities Management, LLC is the general partner of Alta Bioequities, L.P. and may be deemed to have sole voting and investment power over the shares beneficially owned by Alta Bioequities, L.P. The Reporting Person is the Managing Director of Alta Bioequities Management, LLC and may be deemed to have voting and investment power over the shares owned by Alta Bioequities, L.P.

Read SEC document
December 10, 2021 Filed Dec 14, 2021 21:09 UTC
Krishnan Krish SDirector · President and CEO · 10% owner
SaleCommon Stock 100,000 $70.50 $7,050,000.00
Disclosure

SEC source: 0000899243-21-048119 · doc4.xml · nonDerivative · entry 1

Krishnan Krish S · CIK 0001298709 · Director · President and CEO · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · By trust

Disclosed balance after: 50,000

F1 · shares: On December 3, 2021, Krystal Biotech, Inc. (the "Company"), closed the previously announced underwritten public offering of 2,666,667 shares of its common stock, at a public offering price of $75.00 per share. The Company and certain selling stockholders granted the underwriters a 30-day option to purchase up to an additional 400,000 shares of the Company's common stock offered in the public offering, which includes up to 200,000 shares from the selling stockholders. The underwriters exercised the option and on December 10, 2021, purchased the 400,000 shares of the Company's common stock, including 100,000 shares of the Company's common stock from the Krishnan Family Trust, a selling stockholder.

F2 · ownership.nature: Directly beneficially owned by the Krishnan Family Trust. The reporting person and his spouse are each joint beneficial owners of the trust with joint voting and investment control.

F3 · ownership.nature: Prior to the reported transaction, the Krishnan Family Trust held 112,162 shares. In connection with the reported transaction, 18,919 shares were transferred to the Krishnan Family Trust from the reporting person's individual account and 18,919 shares were transferred to the Krishnan Family Trust from Suma Krishnan's, the reporting person's spouse, individual account.

Read SEC document
June 30, 2021 Filed Jul 2, 2021 15:39 UTC
ROSSI DINO ADirector
GrantStock Option (Right to Buy) · Derivative 6,800 $0.00 Strike: $68.00 $0.00
Disclosure

SEC source: 0001711279-21-000022 · wf-form4_162524036673173.xml · derivative · entry 1

ROSSI DINO A · CIK 0001209059 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,800

Underlying: Common Stock · 6,800 shares

Expires 2031-06-30

F1 · derivative.exercise_date: The options were awarded on June 30, 2021 and vest in equal monthly tranches over a one-year period.

Read SEC document
June 30, 2021 Filed Jul 2, 2021 15:36 UTC GrantStock Option (Right to Buy) · Derivative 6,800 $0.00 Strike: $68.00 $0.00
Disclosure

SEC source: 0001711279-21-000020 · wf-form4_162524019238929.xml · derivative · entry 1

JANNEY DANIEL · CIK 0001198325 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,800

Underlying: Common Stock · 6,800 shares

Expires 2031-06-30

F1 · derivative.exercise_date: The options were awarded on June 30, 2021 and vest in equal monthly tranches over a one-year period.

Read SEC document
June 30, 2021 Filed Jul 2, 2021 15:30 UTC GrantStock Option (Right to Buy) · Derivative 6,800 $0.00 Strike: $68.00 $0.00
Disclosure

SEC source: 0001711279-21-000016 · wf-form4_162523981348902.xml · derivative · entry 1

Mason Christopher · CIK 0001836440 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,800

Underlying: Common Stock · 6,800 shares

Expires 2031-06-30

F1 · derivative.exercise_date: The options were awarded on June 30, 2021 and vest in equal monthly tranches over a one-year period.

Read SEC document
June 30, 2021 Filed Jul 2, 2021 15:33 UTC GrantStock Option (Right to Buy) · Derivative 6,800 $0.00 Strike: $68.00 $0.00
Disclosure

SEC source: 0001711279-21-000018 · wf-form4_162524001713056.xml · derivative · entry 1

Gangolli Julian S · CIK 0001532023 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,800

Underlying: Common Stock · 6,800 shares

Expires 2031-06-30

F1 · derivative.exercise_date: The options were awarded on June 30, 2021 and vest in equal monthly tranches over a one-year period.

Read SEC document
June 30, 2021 Filed Jul 2, 2021 15:26 UTC GrantStock Option (Right to Buy) · Derivative 6,800 $0.00 Strike: $68.00 $0.00
Disclosure

SEC source: 0001711279-21-000014 · wf-form4_162523956297359.xml · derivative · entry 1

Marantz Jing L. · CIK 0001834528 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,800

Underlying: Common Stock · 6,800 shares

Expires 2031-06-30

F1 · derivative.exercise_date: The options were awarded on June 30, 2021 and vest in equal monthly tranches over a one-year period.

Read SEC document
May 31, 2021 Filed Jun 2, 2021 19:19 UTC
ORTH ANDREW C.Chief Commercial Officer
GrantStock Option (Right to Buy) · Derivative 205,000 $0.00 Strike: $65.24 $0.00
Disclosure

SEC source: 0000925421-21-000140 · edgar.xml · derivative · entry 2

ORTH ANDREW C. · CIK 0001860010 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 205,000

Underlying: Common Stock · 205,000 shares

Expires 2031-05-31

F1 · derivative.exercise_date: The option vests in four equal annual installments beginning on May 3, 2022.

Read SEC document
February 26, 2021 Filed Mar 2, 2021 20:40 UTC
ROMANO KATHRYNChief Accounting Officer
GrantStock Option (Right to Buy) · Derivative 29,400 $0.00 Strike: $78.89 $0.00
Disclosure

SEC source: 0000899243-21-009163 · doc4.xml · derivative · entry 2

Romano Kathryn · CIK 0001801385 · Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 29,400

Underlying: Common Stock · 29,400 shares

Expires 2025-02-26

F2 · derivative.exercise_date: The option vests in four equal annual installments beginning on February 26, 2022.

Read SEC document
February 26, 2021 Filed Mar 2, 2021 20:40 UTC
ROMANO KATHRYNChief Accounting Officer
GrantCommon Stock 19,600 Not disclosed Not disclosed
Disclosure

SEC source: 0000899243-21-009163 · doc4.xml · nonDerivative · entry 1

Romano Kathryn · CIK 0001801385 · Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,600

F1 · security: Award of restricted stock which vests in four equal annual installments beginning on February 26, 2022.

F1 · shares: Award of restricted stock which vests in four equal annual installments beginning on February 26, 2022.

F1 · price: Award of restricted stock which vests in four equal annual installments beginning on February 26, 2022.

Read SEC document
February 26, 2021 Filed Mar 3, 2021 01:42 UTC
Krishnan SumaDirector · Chief Operating Officer · 10% owner
GrantStock Option (Right to Buy) · Derivative 42,600 $0.00 Strike: $78.89 $0.00
Disclosure

SEC source: 0000899243-21-009168 · doc4.xml · derivative · entry 4

Krishnan Suma · CIK 0001298711 · Director · Chief Operating Officer · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 42,600

Underlying: Common Stock · 42,600 shares

Expires 2025-02-26

F4 · derivative.exercise_date: The option vests in four equal annual installments beginning on February 26, 2022.

Read SEC document
February 26, 2021 Filed Mar 3, 2021 01:42 UTC
Krishnan SumaDirector · Chief Operating Officer · 10% owner
GrantCommon Stock 28,400 Not disclosed Not disclosed
Disclosure

SEC source: 0000899243-21-009168 · doc4.xml · nonDerivative · entry 1

Krishnan Suma · CIK 0001298711 · Director · Chief Operating Officer · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,864,464

F1 · security: Award of restricted stock which vests in four equal annual installments beginning on February 26, 2022.

F1 · shares: Award of restricted stock which vests in four equal annual installments beginning on February 26, 2022.

F1 · price: Award of restricted stock which vests in four equal annual installments beginning on February 26, 2022.

Read SEC document
February 26, 2021 Filed Mar 3, 2021 01:39 UTC
Krishnan Krish SDirector · President and CEO · 10% owner
GrantStock Option (Right to Buy) · Derivative 61,200 $0.00 Strike: $78.89 $0.00
Disclosure

SEC source: 0000899243-21-009162 · doc4.xml · derivative · entry 4

Krishnan Krish S · CIK 0001298709 · Director · President and CEO · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 61,200

Underlying: Common Stock · 61,200 shares

Expires 2025-02-26

F4 · derivative.exercise_date: The option vests in four equal annual installments beginning on February 26, 2022.

Read SEC document
February 26, 2021 Filed Mar 3, 2021 01:39 UTC
Krishnan Krish SDirector · President and CEO · 10% owner
GrantCommon Stock 40,800 Not disclosed Not disclosed
Disclosure

SEC source: 0000899243-21-009162 · doc4.xml · nonDerivative · entry 1

Krishnan Krish S · CIK 0001298709 · Director · President and CEO · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,927,262

F1 · security: Award of restricted stock which vests in four equal annual installments beginning on February 26, 2022.

F1 · shares: Award of restricted stock which vests in four equal annual installments beginning on February 26, 2022.

F1 · price: Award of restricted stock which vests in four equal annual installments beginning on February 26, 2022.

Read SEC document
January 04, 2021 Filed Jan 5, 2021 22:14 UTC GrantStock Option (Right to Buy) · Derivative 13,600 $0.00 Strike: $59.42 $0.00
Disclosure

SEC source: 0000899243-21-000413 · doc4.xml · derivative · entry 1

Marantz Jing L. · CIK 0001834528 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,600

Underlying: Common Stock · 13,600 shares

Expires 2031-01-04

F1 · derivative.exercise_date: The options were awarded on January 4, 2021 and vest in equal amounts over 36 months.

Read SEC document
January 04, 2021 Filed Jan 5, 2021 22:07 UTC GrantStock Option (Right to Buy) · Derivative 13,600 $0.00 Strike: $59.42 $0.00
Disclosure

SEC source: 0000899243-21-000410 · doc4.xml · derivative · entry 1

Mason Christopher · CIK 0001836440 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,600

Underlying: Common Stock · 13,600 shares

Expires 2031-01-04

F1 · derivative.exercise_date: The options were awarded on January 4, 2021 and vest in equal amounts over 36 months.

Read SEC document
September 17, 2020 Filed Sep 17, 2020 22:35 UTC
Krishnan SumaDirector · Chief Operating Officer · 10% owner
SaleCommon Stock 1,126 $47.29 $53,248.31
Disclosure

SEC source: 0000899243-20-025576 · doc4.xml · nonDerivative · entry 7

Krishnan Suma · CIK 0001298711 · Director · Chief Operating Officer · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,836,064

F1 · kind: The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person following discussions with the Compensation Committee and the Board of Directors. The Rule 10b5-1 trading plan has now expired.

F8 · price: This transaction was executed in multiple trades ranging from $47.27 to $47.34. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.

Read SEC document
September 17, 2020 Filed Sep 17, 2020 22:35 UTC
Krishnan SumaDirector · Chief Operating Officer · 10% owner
SaleCommon Stock 7,437 $46.63 $346,813.34
Disclosure

SEC source: 0000899243-20-025576 · doc4.xml · nonDerivative · entry 6

Krishnan Suma · CIK 0001298711 · Director · Chief Operating Officer · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,837,190

F1 · kind: The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person following discussions with the Compensation Committee and the Board of Directors. The Rule 10b5-1 trading plan has now expired.

F7 · price: This transaction was executed in multiple trades ranging from $46.27 to $47.24. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.

Read SEC document
September 17, 2020 Filed Sep 17, 2020 22:35 UTC
Krishnan SumaDirector · Chief Operating Officer · 10% owner
SaleCommon Stock 10,594 $46.09 $488,296.53
Disclosure

SEC source: 0000899243-20-025576 · doc4.xml · nonDerivative · entry 5

Krishnan Suma · CIK 0001298711 · Director · Chief Operating Officer · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,844,627

F1 · kind: The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person following discussions with the Compensation Committee and the Board of Directors. The Rule 10b5-1 trading plan has now expired.

F6 · price: This transaction was executed in multiple trades ranging from $45.27 to $46.26. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.

Read SEC document
September 16, 2020 Filed Sep 17, 2020 22:35 UTC
Krishnan SumaDirector · Chief Operating Officer · 10% owner
SaleCommon Stock 5,142 $46.85 $240,895.50
Disclosure

SEC source: 0000899243-20-025576 · doc4.xml · nonDerivative · entry 4

Krishnan Suma · CIK 0001298711 · Director · Chief Operating Officer · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,855,221

F1 · kind: The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person following discussions with the Compensation Committee and the Board of Directors. The Rule 10b5-1 trading plan has now expired.

F5 · price: This transaction was executed in multiple trades ranging from $46.64 to $47.14. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.

Read SEC document
September 16, 2020 Filed Sep 17, 2020 22:35 UTC
Krishnan SumaDirector · Chief Operating Officer · 10% owner
SaleCommon Stock 9,749 $46.24 $450,821.06
Disclosure

SEC source: 0000899243-20-025576 · doc4.xml · nonDerivative · entry 3

Krishnan Suma · CIK 0001298711 · Director · Chief Operating Officer · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,860,363

F1 · kind: The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person following discussions with the Compensation Committee and the Board of Directors. The Rule 10b5-1 trading plan has now expired.

F4 · price: This transaction was executed in multiple trades ranging from $45.64 to $46.62. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.

Read SEC document
September 15, 2020 Filed Sep 17, 2020 22:35 UTC
Krishnan SumaDirector · Chief Operating Officer · 10% owner
SaleCommon Stock 1,517 $47.15 $71,523.21
Disclosure

SEC source: 0000899243-20-025576 · doc4.xml · nonDerivative · entry 2

Krishnan Suma · CIK 0001298711 · Director · Chief Operating Officer · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,870,112

F1 · kind: The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person following discussions with the Compensation Committee and the Board of Directors. The Rule 10b5-1 trading plan has now expired.

F3 · price: This transaction was executed in multiple trades ranging from $46.76 to $47.66. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.

Read SEC document
September 15, 2020 Filed Sep 17, 2020 22:35 UTC
Krishnan SumaDirector · Chief Operating Officer · 10% owner
SaleCommon Stock 14,435 $46.21 $667,031.25
Disclosure

SEC source: 0000899243-20-025576 · doc4.xml · nonDerivative · entry 1

Krishnan Suma · CIK 0001298711 · Director · Chief Operating Officer · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,871,629

F1 · kind: The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person following discussions with the Compensation Committee and the Board of Directors. The Rule 10b5-1 trading plan has now expired.

F2 · price: This transaction was executed in multiple trades ranging from $45.76 to $46.75. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.

Read SEC document
June 30, 2020 Filed Aug 8, 2020 00:43 UTC
ROSSI DINO ADirector
GrantStock Option (Right to Buy) · Derivative 6,800 $0.00 Strike: $41.42 $0.00
Disclosure

SEC source: 0000899243-20-021815 · doc4.xml · derivative · entry 1

ROSSI DINO A · CIK 0001209059 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,800

Underlying: Common Stock · 6,800 shares

Expires 2030-06-29

F1 · derivative.exercise_date: The options were awarded on June 30, 2020 and vest in equal monthly tranches over a one-year period.

Read SEC document
June 30, 2020 Filed Aug 8, 2020 00:22 UTC GrantStock Option (Right to Buy) · Derivative 6,800 $0.00 Strike: $41.42 $0.00
Disclosure

SEC source: 0000899243-20-021813 · doc4.xml · derivative · entry 1

Gangolli Julian S · CIK 0001532023 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,800

Underlying: Common Stock · 6,800 shares

Expires 2030-06-29

F1 · derivative.exercise_date: The options were awarded on June 30, 2020 and vest in equal monthly tranches over a one-year period.

Read SEC document
June 30, 2020 Filed Aug 8, 2020 00:10 UTC GrantStock Option (Right to Buy) · Derivative 6,800 $0.00 Strike: $41.42 $0.00
Disclosure

SEC source: 0000899243-20-021806 · doc4.xml · derivative · entry 1

JANNEY DANIEL · CIK 0001198325 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,800

Underlying: Common Stock · 6,800 shares

Expires 2030-06-29

F1 · derivative.exercise_date: The options were awarded on June 30, 2020 and vest in equal monthly tranches over a one-year period.

Read SEC document
June 15, 2020 Filed Jun 17, 2020 20:14 UTC
Krishnan SumaDirector · Chief Operating Officer · 10% owner
SaleCommon Stock 11,719 $45.07 $528,182.36
Disclosure

SEC source: 0000899243-20-016834 · doc4.xml · nonDerivative · entry 5

Krishnan Suma · CIK 0001298711 · Director · Chief Operating Officer · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,886,064

F1 · kind: The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person following discussions with the Compensation Committee and the Board of Directors.

F6 · price: This transaction was executed in multiple trades ranging from $44.91 to $45.50. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.

Read SEC document
June 15, 2020 Filed Jun 17, 2020 20:14 UTC
Krishnan SumaDirector · Chief Operating Officer · 10% owner
SaleCommon Stock 11,311 $44.56 $504,057.75
Disclosure

SEC source: 0000899243-20-016834 · doc4.xml · nonDerivative · entry 4

Krishnan Suma · CIK 0001298711 · Director · Chief Operating Officer · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,897,783

F1 · kind: The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person following discussions with the Compensation Committee and the Board of Directors.

F5 · price: This transaction was executed in multiple trades ranging from $43.91 to $44.90. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.

Read SEC document
June 15, 2020 Filed Jun 17, 2020 20:14 UTC
Krishnan SumaDirector · Chief Operating Officer · 10% owner
SaleCommon Stock 10,740 $43.21 $464,070.03
Disclosure

SEC source: 0000899243-20-016834 · doc4.xml · nonDerivative · entry 3

Krishnan Suma · CIK 0001298711 · Director · Chief Operating Officer · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,909,094

F1 · kind: The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person following discussions with the Compensation Committee and the Board of Directors.

F4 · price: This transaction was executed in multiple trades ranging from $42.85 to $43.77. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.

Read SEC document
June 15, 2020 Filed Jun 17, 2020 20:14 UTC
Krishnan SumaDirector · Chief Operating Officer · 10% owner
SaleCommon Stock 8,652 $42.24 $365,426.74
Disclosure

SEC source: 0000899243-20-016834 · doc4.xml · nonDerivative · entry 2

Krishnan Suma · CIK 0001298711 · Director · Chief Operating Officer · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,919,834

F1 · kind: The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person following discussions with the Compensation Committee and the Board of Directors.

F3 · price: This transaction was executed in multiple trades ranging from $41.84 to $42.83. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide

Read SEC document
June 15, 2020 Filed Jun 17, 2020 20:14 UTC
Krishnan SumaDirector · Chief Operating Officer · 10% owner
SaleCommon Stock 7,578 $41.31 $313,038.09
Disclosure

SEC source: 0000899243-20-016834 · doc4.xml · nonDerivative · entry 1

Krishnan Suma · CIK 0001298711 · Director · Chief Operating Officer · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,928,486

F1 · kind: The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person following discussions with the Compensation Committee and the Board of Directors.

F2 · price: This transaction was executed in multiple trades ranging from $40.84 to $41.77. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.

Read SEC document
May 18, 2020 Filed May 19, 2020 21:01 UTC
Krishnan Krish SDirector · President and CEO · 10% owner
SaleCommon Stock 6,301 $59.73 $376,344.87
Disclosure

SEC source: 0001209191-20-030562 · doc4.xml · nonDerivative · entry 8

Krishnan Krish S · CIK 0001298709 · Director · President and CEO · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,886,462

F1 · kind: The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person following discussions with the Compensation Committee and the Board of Directors.

F9 · price: This transaction was executed in multiple trades ranging from $59.42 to $60.15. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.